HK1214864A1 - 用於腎損傷和腎衰竭的診斷及預後的方法和組合物 - Google Patents

用於腎損傷和腎衰竭的診斷及預後的方法和組合物

Info

Publication number
HK1214864A1
HK1214864A1 HK16102829.5A HK16102829A HK1214864A1 HK 1214864 A1 HK1214864 A1 HK 1214864A1 HK 16102829 A HK16102829 A HK 16102829A HK 1214864 A1 HK1214864 A1 HK 1214864A1
Authority
HK
Hong Kong
Prior art keywords
renal
prognosis
diagnosis
compositions
methods
Prior art date
Application number
HK16102829.5A
Other languages
English (en)
Inventor
．安德貝里
．格雷
．中村
．坎普夫
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of HK1214864A1 publication Critical patent/HK1214864A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/521—Chemokines
    • G01N2333/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1or LDCF-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
HK16102829.5A 2009-11-07 2016-03-11 用於腎損傷和腎衰竭的診斷及預後的方法和組合物 HK1214864A1 (zh)

Applications Claiming Priority (22)

Application Number Priority Date Filing Date Title
US25913609P 2009-11-07 2009-11-07
US25915909P 2009-11-07 2009-11-07
US25914709P 2009-11-07 2009-11-07
US25915709P 2009-11-07 2009-11-07
US25913909P 2009-11-07 2009-11-07
US25914509P 2009-11-07 2009-11-07
US25916009P 2009-11-07 2009-11-07
US25915109P 2009-11-07 2009-11-07
US25914809P 2009-11-07 2009-11-07
US25915509P 2009-11-07 2009-11-07
US25915309P 2009-11-07 2009-11-07
US25916209P 2009-11-07 2009-11-07
US25915609P 2009-11-07 2009-11-07
US25913709P 2009-11-07 2009-11-07
US25916109P 2009-11-07 2009-11-07
US25913509P 2009-11-07 2009-11-07
US25915209P 2009-11-07 2009-11-07
US28592809P 2009-12-11 2009-12-11
US28592909P 2009-12-11 2009-12-11
US32072310P 2010-04-03 2010-04-03
US34654710P 2010-05-20 2010-05-20
US34655110P 2010-05-20 2010-05-20

Publications (1)

Publication Number Publication Date
HK1214864A1 true HK1214864A1 (zh) 2016-08-05

Family

ID=43970376

Family Applications (2)

Application Number Title Priority Date Filing Date
HK12111912.8A HK1170955A1 (zh) 2009-11-07 2012-11-21 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
HK16102829.5A HK1214864A1 (zh) 2009-11-07 2016-03-11 用於腎損傷和腎衰竭的診斷及預後的方法和組合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK12111912.8A HK1170955A1 (zh) 2009-11-07 2012-11-21 用於腎損傷和腎衰竭的診斷及預後的方法和組合物

Country Status (10)

Country Link
EP (2) EP3153863B1 (zh)
JP (2) JP2013510321A (zh)
CN (2) CN104914247B (zh)
AU (2) AU2010314999B2 (zh)
CA (1) CA2779905A1 (zh)
EA (1) EA201290195A1 (zh)
HK (2) HK1170955A1 (zh)
MX (1) MX2012005210A (zh)
NZ (2) NZ624614A (zh)
WO (1) WO2011057138A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013023233A1 (en) * 2011-08-12 2013-02-21 Alfred Health Method for diagnosis, prognosis or treatment of acute coronary syndrome (acs) comprising measurement of plasma concentration of macrophage migration inhibitory factor (mif)
WO2013096740A1 (en) * 2011-12-21 2013-06-27 Alere San Diego Inc. Methods and compositions for assigning likelihood of chronic kidney disease progression
KR102431003B1 (ko) * 2014-10-20 2022-08-09 아스튜트 메디컬 인코포레이티드 신손상 및 신부전의 진단 및 예후를 위한 방법 및 조성물
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
JP6793748B2 (ja) 2015-12-18 2020-12-02 タレンゲン インターナショナル リミテッドＴａｌｅｎｇｅｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｌｉｍｉｔｅｄ 放射性および化学的損傷を予防及び治療するための方法
TWI623321B (zh) 2015-12-18 2018-05-11 Talengen Institute Of Life Sciences Co Ltd Method for preventing and treating cervical erosion
CN107345968A (zh) * 2016-05-05 2017-11-14 中国医学科学院基础医学研究所 Cecam1蛋白作为血清标记物在诊断肝脏疾病中的用途
TWI657823B (zh) 2016-12-15 2019-05-01 大陸商深圳瑞健生命科學研究院有限公司 一種預防和治療系統性硬化症的方法
CN108210894A (zh) * 2016-12-15 2018-06-29 深圳瑞健生命科学研究院有限公司 预防和治疗病理性肾组织损伤的药物及其用途
US11353465B2 (en) 2017-01-12 2022-06-07 Astute Medical, Inc. Methods and compositions for evaluation and treatment of renal injury and renal failure based on C—C motif chemokine ligand 14 measurement
CA3067890A1 (en) 2017-06-19 2018-12-27 Talengen International Limited Method for regulating and controling glp-1/glp-1r and drug
EP4071480A1 (en) * 2021-04-09 2022-10-12 Fundació Ace. Institut Català de Neurociències Aplicades Cerebrospinal fluid biomarker for alzheimer's disease
WO2024040225A2 (en) * 2022-08-19 2024-02-22 The Johns Hopkins University Diagnosis and treatment of acute kidney injury

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
WO1992005282A1 (en) 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
JPH06506688A (ja) 1991-04-10 1994-07-28 バイオサイト・ダイアグノスティックス・インコーポレイテッド クロストークインヒビターおよびその使用
EP0579767B1 (en) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Novel conjugates and assays for simultaneous detection of multiple ligands
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
JP2007078705A (ja) * 1997-04-04 2007-03-29 Seikagaku Kogyo Co Ltd ヘパラン硫酸の定量方法及び定量キット
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
MXPA01006404A (es) * 1998-12-21 2003-06-06 Univ Monash Deteccion y tratamiento de enfermedad renal.
WO2001088544A2 (en) * 2000-05-17 2001-11-22 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Proteolytic enzymes in diagnosis of kidney disorders
US20030003588A1 (en) * 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
US7560244B2 (en) * 2003-06-04 2009-07-14 Joslin Diabetes Center, Inc. Method of evaluating a subject for risk or predisposition of reduced renal function over time
CA2589374C (en) * 2004-11-30 2016-05-03 Curagen Corporation Antibodies directed to gpnmb and uses thereof
EP1808694A1 (en) * 2006-01-17 2007-07-18 Universitätsklinikum Freiburg Method for diagnosing polycystic kidney disease
WO2008133641A2 (en) * 2006-10-11 2008-11-06 Curagen Corporation Antibodies directed to gpnmb and uses thereof
JP2008118915A (ja) * 2006-11-10 2008-05-29 Kazuto Nishio 胃癌高発現遺伝子特定による胃癌診断および創薬への利用
EP2095107B1 (en) * 2006-11-14 2014-07-02 Alere San Diego, Inc. Methods for risk assignment
CN104399089B (zh) * 2008-10-21 2017-04-19 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
US8460884B2 (en) * 2008-11-05 2013-06-11 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Use of hematopoietic growth factor inducible neurokinin-1 (HGFIN) as a biomarker for renal injury or renal disease

Also Published As

Publication number Publication date
AU2010314999A1 (en) 2012-06-14
CN102711827B (zh) 2015-05-20
HK1170955A1 (zh) 2013-03-15
MX2012005210A (es) 2012-08-03
EP3153863A1 (en) 2017-04-12
EP2496258A4 (en) 2013-06-26
JP2013510321A (ja) 2013-03-21
NZ624614A (en) 2015-10-30
CN104914247B (zh) 2018-04-17
EP2496258A1 (en) 2012-09-12
CN102711827A (zh) 2012-10-03
NZ600160A (en) 2014-05-30
CN104914247A (zh) 2015-09-16
JP6609533B2 (ja) 2019-11-20
EA201290195A1 (ru) 2012-12-28
AU2010314999B2 (en) 2014-06-26
JP2017026627A (ja) 2017-02-02
EP2496258B1 (en) 2016-11-02
EP3153863B1 (en) 2020-04-01
WO2011057138A1 (en) 2011-05-12
AU2014224137A1 (en) 2014-10-02
CA2779905A1 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
HK1211082A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
HK1212776A1 (zh) 用於診斷和預後腎損傷和腎衰竭的方法和組合物
HK1213320A1 (zh) 用於診斷和預後腎損傷和腎衰竭的方法和組合物
EP2480882A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL LESIONS AND FAILURES
HK1203619A1 (zh) 用於診斷和預後腎損傷和腎衰竭的方法和組合物
HK1208074A1 (zh) 腎損傷和腎衰竭的診斷及預後的方法及組合物
HK1199929A1 (zh) 用於診斷和預後腎損傷和腎衰竭的方法和組合物
HK1167455A1 (zh) 用於腎損傷和腎衰竭的診斷及預後方法和組合物
HK1199931A1 (zh) 用於診斷和預後腎損傷和腎衰竭的方法和組合物
HK1159755A1 (zh) 用於診斷和預後腎損傷和腎衰竭的方法和組合物
EP2539712A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
HK1214864A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
EP2531620A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
HK1200218A1 (zh) 腎損傷和腎衰竭的診斷和預後
HK1167888A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的組合物和方法
HK1211084A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
EP2625524A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
HK1212774A1 (zh) 用於腎損傷和腎衰竭的診斷及預後方法和組合物
EP2462446A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
EP2531622A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
EP2531621A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
EP2593794A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
HK1197298A1 (zh) 用於診斷和預後腎損傷和腎衰竭的方法和組合物

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20221110